Relaxo Footwears Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 26, 2025, 11:17 am

Market Cap	10,459 Cr.
Current Price	420
High / Low	888/375
Stock P/E	61.4
Book Value	84.3
Dividend Yield	0.72 %
ROCE	11.1 %
ROE	8.31 %
Face Value	1.00
PEG Ratio	-6.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Relaxo Footwears Ltd

Competitors of Relaxo Footwears Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Campus Activewear Ltd	8,687 Cr.	284	372/210	71.7	24.8	0.25 %	20.1 %	17.2 %	5.00
AKI India Ltd	81.6 Cr.	7.91	26.8/6.63	50.1	7.33	0.00 %	5.44 %	2.62 %	2.00
Relaxo Footwears Ltd	10,459 Cr.	420	888/375	61.4	84.3	0.72 %	11.1 %	8.31 %	1.00
Liberty Shoes Ltd	699 Cr.	410	570/276	45.6	131	0.00 %	10.0 %	7.09 %	10.0
Khadim India Ltd	486 Cr.	265	370/210	25.1	137	0.00 %	8.47 %	7.90 %	10.0
Industry Average	7,210.40 Cr	434.99		53.25	84.57	0.33%	11.62%	9.75%	5.50

All Competitor Stocks of Relaxo Footwears Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	698	667	670	681	765	739	715	713	747	748	679	667	695
Expenses	587	581	610	609	647	631	624	626	627	649	592	584	583
Operating Profit	111	86	59	72	118	108	92	87	120	99	88	83	112
OPM %	16%	13%	9%	11%	15%	15%	13%	12%	16%	13%	13%	12%	16%
Other Income	6	4	6	4	4	7	11	6	5	5	7	7	8
Interest	4	7	4	4	4	4	5	5	5	5	5	5	5
Depreciation	29	30	31	32	33	35	37	38	38	39	40	40	39
Profit before tax	84	54	30	41	85	76	60	51	82	60	50	45	75
Tax %	25%	28%	26%	26%	26%	26%	27%	24%	25%	26%	26%	26%	25%
Net Profit	63	39	22	30	63	56	44	39	61	44	37	33	56
EPS in Rs	2.53	1.55	0.90	1.21	2.54	2.26	1.78	1.55	2.47	1.78	1.48	1.33	2.26

Last Updated: May 31, 2025, 7:58 am

Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 695.00 Cr.. The value appears strong and on an upward trend. It has increased from 667.00 Cr. (Dec 2024) to 695.00 Cr., marking an increase of 28.00 Cr..
For Expenses, as of Mar 2025, the value is 583.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 584.00 Cr. (Dec 2024) to 583.00 Cr., marking a decrease of 1.00 Cr..
For Operating Profit, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Dec 2024) to 112.00 Cr., marking an increase of 29.00 Cr..
For OPM %, as of Mar 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 16.00%, marking an increase of 4.00%.
For Other Income, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
For Interest, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
For Depreciation, as of Mar 2025, the value is 39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Dec 2024) to 39.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Dec 2024) to 75.00 Cr., marking an increase of 30.00 Cr..
For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Dec 2024) to 25.00%, marking a decrease of 1.00%.
For Net Profit, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Dec 2024) to 56.00 Cr., marking an increase of 23.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.26. The value appears strong and on an upward trend. It has increased from 1.33 (Dec 2024) to 2.26, marking an increase of 0.93.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:19 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	1,180	1,441	1,668	1,631	1,941	2,292	2,410	2,359	2,653	2,783	2,914	2,790
Expenses	1,032	1,240	1,427	1,400	1,639	1,964	1,998	1,861	2,235	2,442	2,503	2,408
Operating Profit	148	201	241	231	302	328	413	498	418	341	411	382
OPM %	13%	14%	14%	14%	16%	14%	17%	21%	16%	12%	14%	14%
Other Income	2	0	7	14	4	12	8	22	23	16	26	27
Interest	23	18	23	15	9	9	19	19	17	22	21	21
Depreciation	31	40	47	51	54	62	109	110	114	125	147	158
Profit before tax	96	143	178	178	244	268	292	391	311	210	269	230
Tax %	31%	28%	32%	33%	34%	35%	22%	25%	25%	26%	26%	26%
Net Profit	66	103	120	120	161	175	226	292	233	154	200	170
EPS in Rs	2.74	4.29	5.01	4.99	6.69	7.07	9.11	11.74	9.35	6.21	8.05	6.84
Dividend Payout %	5%	6%	6%	10%	11%	13%	14%	21%	27%	40%	37%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	56.06%	16.50%	0.00%	34.17%	8.70%	29.14%	29.20%	-20.21%	-33.91%	29.87%	-15.00%
Change in YoY Net Profit Growth (%)	0.00%	-39.56%	-16.50%	34.17%	-25.47%	20.45%	0.06%	-49.41%	-13.70%	63.78%	-44.87%

Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	3%
3 Years:	2%
TTM:	-4%

Compounded Profit Growth
10 Years:	5%
5 Years:	-6%
3 Years:	-10%
TTM:	-16%

Stock Price CAGR
10 Years:	7%
5 Years:	-8%
3 Years:	-24%
1 Year:	-49%

Return on Equity
10 Years:	15%
5 Years:	12%
3 Years:	9%
Last Year:	8%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:50 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	6	6	12	12	12	12	25	25	25	25	25	25
Reserves	271	362	468	594	749	1,093	1,248	1,548	1,735	1,830	1,976	2,073
Borrowings	198	239	236	178	153	112	139	144	174	164	205	213
Other Liabilities	182	234	281	286	335	394	430	459	448	476	508	452
Total Liabilities	657	841	997	1,070	1,250	1,611	1,841	2,176	2,383	2,495	2,714	2,762
Fixed Assets	366	472	531	541	525	848	981	938	987	1,150	1,371	1,345
CWIP	24	2	28	62	138	11	46	118	149	89	33	53
Investments	0	0	0	1	1	0	0	338	194	225	108	343
Other Assets	267	367	438	466	587	752	814	782	1,052	1,030	1,202	1,021
Total Assets	657	841	997	1,070	1,250	1,611	1,841	2,176	2,383	2,495	2,714	2,762

Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
For Reserves, as of Mar 2025, the value is 2,073.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,976.00 Cr. (Mar 2024) to 2,073.00 Cr., marking an increase of 97.00 Cr..
For Borrowings, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 205.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 8.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 452.00 Cr.. The value appears to be improving (decreasing). It has decreased from 508.00 Cr. (Mar 2024) to 452.00 Cr., marking a decrease of 56.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 2,762.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,714.00 Cr. (Mar 2024) to 2,762.00 Cr., marking an increase of 48.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 1,345.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,371.00 Cr. (Mar 2024) to 1,345.00 Cr., marking a decrease of 26.00 Cr..
For CWIP, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 20.00 Cr..
For Investments, as of Mar 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2024) to 343.00 Cr., marking an increase of 235.00 Cr..
For Other Assets, as of Mar 2025, the value is 1,021.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,202.00 Cr. (Mar 2024) to 1,021.00 Cr., marking a decrease of 181.00 Cr..
For Total Assets, as of Mar 2025, the value is 2,762.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,714.00 Cr. (Mar 2024) to 2,762.00 Cr., marking an increase of 48.00 Cr..

Notably, the Reserves (2,073.00 Cr.) exceed the Borrowings (213.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	125	107	159	180	154	123	319	513	56	400	235	406
Cash from Investing Activity +	-70	-130	-130	-89	-108	-56	-116	-453	15	-258	-99	-262
Cash from Financing Activity +	-51	21	-31	-89	-46	-68	-203	-56	-70	-138	-106	-162
Net Cash Flow	4	-1	-2	1	-0	-1	1	4	1	3	30	-18

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-50.00	-38.00	5.00	53.00	149.00	216.00	274.00	354.00	244.00	177.00	206.00	169.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	13	21	21	24	28	33	35	26	28	34	35	45
Inventory Days	124	109	163	147	146	130	130	157	154	202	154	179
Days Payable	35	39	61	63	63	72	58	65	81	67	69	76
Cash Conversion Cycle	102	91	123	108	110	90	107	119	101	170	121	148
Working Capital Days	31	20	31	32	32	43	56	60	49	82	64	75
ROCE %	22%	26%	30%	30%	26%	30%	26%	24%	26%	18%	12%	14%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	70.92%	70.78%	70.78%	70.78%	70.78%	71.02%	71.25%	71.27%	71.27%	71.27%	71.27%	71.27%
FIIs	3.56%	3.81%	3.22%	3.15%	3.11%	2.99%	2.82%	2.87%	3.24%	3.39%	3.32%	3.36%
DIIs	7.17%	7.08%	6.94%	7.07%	7.43%	7.64%	7.96%	8.34%	8.53%	8.86%	9.33%	9.54%
Public	18.35%	18.33%	19.06%	19.00%	18.68%	18.34%	17.98%	17.51%	16.96%	16.47%	16.07%	15.82%
No. of Shareholders	2,23,393	2,60,562	3,10,079	3,28,969	3,45,741	3,61,927	3,58,700	3,43,295	3,16,135	2,91,401	2,69,388	2,52,981

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Focused Equity Fund	8,604,916	2.03	711.88	8,604,916	2025-04-22 15:17:20	0%
SBI Equity Hybrid Fund	2,533,988	0.29	209.64	2,533,988	2025-04-22 15:16:47	0%
SBI Magnum Midcap Fund	2,500,000	1.02	206.83	2,500,000	2025-04-22 15:56:54	0%
SBI Small Cap Fund	1,800,000	0.48	148.91	1,800,000	2025-04-22 14:12:24	0%
SBI Multicap Fund	1,621,704	0.79	134.16	1,621,704	2025-04-22 15:56:54	0%
SBI Large & Midcap Fund	1,550,000	0.5	128.23	1,550,000	2025-04-22 15:56:54	0%
UTI Flexi Cap Fund	1,526,688	0.49	126.3	1,526,688	2025-04-22 15:56:54	0%
SBI Flexi Cap Fund	1,347,099	0.51	111.45	1,347,099	2025-04-22 15:56:54	0%
SBI Magnum Childrens Benefit Fund - Investment Plan	400,000	1.42	33.09	400,000	2025-04-22 15:56:54	0%
Sundaram Large and Mid Cap Fund	348,399	0.42	28.82	348,399	2025-04-22 15:56:54	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	6.84	8.05	6.21	9.36	11.74
Diluted EPS (Rs.)	6.84	8.05	6.21	9.35	11.74
Cash EPS (Rs.)	13.21	13.98	11.23	13.91	16.17
Book Value[Excl.RevalReserv]/Share (Rs.)	84.29	80.40	74.53	70.72	63.30
Book Value[Incl.RevalReserv]/Share (Rs.)	84.29	80.40	74.53	70.72	63.30
Dividend / Share (Rs.)	3.00	3.00	2.50	2.50	2.50
Revenue From Operations / Share (Rs.)	112.08	117.08	111.80	106.60	94.97
PBDIT / Share (Rs.)	16.43	17.49	14.24	17.66	20.86
PBIT / Share (Rs.)	10.07	11.57	9.21	13.09	16.43
PBT / Share (Rs.)	9.24	10.82	8.44	12.48	15.75
Net Profit / Share (Rs.)	6.84	8.05	6.21	9.35	11.74
PBDIT Margin (%)	14.66	14.94	12.73	16.56	21.96
PBIT Margin (%)	8.98	9.88	8.23	12.28	17.30
PBT Margin (%)	8.24	9.24	7.54	11.70	16.58
Net Profit Margin (%)	6.10	6.87	5.55	8.76	12.35
Return on Networth / Equity (%)	8.11	10.01	8.32	13.21	18.54
Return on Capital Employeed (%)	10.83	13.12	11.32	16.96	23.64
Return On Assets (%)	6.16	7.38	6.19	9.76	13.40
Total Debt / Equity (X)	0.00	0.01	0.00	0.01	0.00
Asset Turnover Ratio (%)	1.02	1.12	1.14	1.16	1.17
Current Ratio (X)	2.74	2.40	2.54	2.57	2.40
Quick Ratio (X)	1.50	1.25	1.34	1.11	1.46
Inventory Turnover Ratio (X)	1.79	1.99	1.91	2.39	1.99
Dividend Payout Ratio (NP) (%)	0.00	31.04	40.28	26.69	0.00
Dividend Payout Ratio (CP) (%)	0.00	17.88	22.25	17.93	0.00
Earning Retention Ratio (%)	0.00	68.96	59.72	73.31	0.00
Cash Earning Retention Ratio (%)	0.00	82.12	77.75	82.07	0.00
Interest Coverage Ratio (X)	19.79	23.30	18.42	28.67	30.34
Interest Coverage Ratio (Post Tax) (X)	9.24	11.73	9.03	16.18	18.07
Enterprise Value (Cr.)	10084.44	20231.08	21055.11	26520.33	21706.20
EV / Net Operating Revenue (X)	3.61	6.94	7.57	10.00	9.20
EV / EBITDA (X)	24.66	46.46	59.42	60.35	41.88
MarketCap / Net Operating Revenue (X)	3.63	6.97	7.59	9.99	9.20
Retention Ratios (%)	0.00	68.95	59.71	73.30	0.00
Price / BV (X)	4.83	10.15	11.39	15.06	13.81
Price / Net Operating Revenue (X)	3.63	6.97	7.59	9.99	9.20
EarningsYield	0.01	0.01	0.01	0.01	0.01

After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.79. This value is below the healthy minimum of 4. It has decreased from 1.99 (Mar 24) to 1.79, marking a decrease of 0.20.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 31.04 (Mar 24) to 0.00, marking a decrease of 31.04.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 17.88 (Mar 24) to 0.00, marking a decrease of 17.88.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 68.96 (Mar 24) to 0.00, marking a decrease of 68.96.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 82.12 (Mar 24) to 0.00, marking a decrease of 82.12.
For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 68.95 (Mar 24) to 0.00, marking a decrease of 68.95.
For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Relaxo Footwears Ltd as of June 26, 2025 is: 346.58

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 26, 2025, Relaxo Footwears Ltd is Overvalued by 17.48% compared to the current share price 420.00

Intrinsic Value of Relaxo Footwears Ltd as of June 26, 2025 is: 311.09

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 26, 2025, Relaxo Footwears Ltd is Overvalued by 25.93% compared to the current share price 420.00

Last 5 Year EPS CAGR: -10.24%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 23.67%, which is a positive sign. The company has higher reserves (1,162.25 cr) compared to borrowings (179.58 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.58 cr) and profit (234.17 cr) over the years.	The stock has a high average Working Capital Days of 47.92, which may not be favorable. The stock has a high average Cash Conversion Cycle of 115.83, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
1. Net Profit Margin: 6.1%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 10.83% (Industry Average ROCE: 11.62%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 8.11% (Industry Average ROE: 9.75%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 9.24
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.5
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 61.4 (Industry average Stock P/E: 53.25)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Relaxo Footwears Ltd. is a Public Limited Listed company incorporated on 13/09/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1984PLC019097 and registration number is 019097. Currently Company is involved in the business activities of Manufacture of footwear. Company's Total Operating Revenue is Rs. 2789.61 Cr. and Equity Capital is Rs. 24.89 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Footwears	Aggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085	rfl@relaxofootwear.com http://www.relaxofootwear.com

Management
Name	Position Held
Mr. Ramesh Kumar Dua	Chairman & Managing Director
Mr. Mukand Lal Dua	Whole Time Director
Mr. Nikhil Dua	Whole Time Director
Mr. Gaurav Dua	Whole Time Director
Mr. Sushil Batra	Executive Director & CFO
Ms. Deepa Verma	Independent Director
Mr. Kuldip Singh Dhingra	Independent Director
Mr. Rajeev Rupendra Bhadauria	Independent Director
Mr. Yogesh Kapur	Independent Director
Mr. Raj Kumar Jain	Independent Director
Ms. Richa Arora	Independent Director

FAQ

What is the intrinsic value of Relaxo Footwears Ltd?

Relaxo Footwears Ltd's intrinsic value (as of 26 June 2025) is ₹346.58 — 17.48% lower the current market price of 420.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,459 Cr. market cap, FY2025-2026 high/low of ₹888/375, reserves of 2,073 Cr, and liabilities of 2,762 Cr.

What is the Market Cap of Relaxo Footwears Ltd?

The Market Cap of Relaxo Footwears Ltd is 10,459 Cr..

What is the current Stock Price of Relaxo Footwears Ltd as on 26 June 2025?

The current stock price of Relaxo Footwears Ltd as on 26 June 2025 is 420.

What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is ₹888/375.

What is the Stock P/E of Relaxo Footwears Ltd?

The Stock P/E of Relaxo Footwears Ltd is 61.4.

What is the Book Value of Relaxo Footwears Ltd?

The Book Value of Relaxo Footwears Ltd is 84.3.

What is the Dividend Yield of Relaxo Footwears Ltd?

The Dividend Yield of Relaxo Footwears Ltd is 0.72 %.

What is the ROCE of Relaxo Footwears Ltd?

The ROCE of Relaxo Footwears Ltd is 11.1 %.

What is the ROE of Relaxo Footwears Ltd?

The ROE of Relaxo Footwears Ltd is 8.31 %.

What is the Face Value of Relaxo Footwears Ltd?

The Face Value of Relaxo Footwears Ltd is 1.00.